JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5126
NACCO Industries
NC
$277M
| $112K | ﹤0.01% |
3,105
+811
| +35% | +$30.4K |
2013 Q2
39 quarters
|
|
5127
Arqit Quantum
ARQQ
$412M
| $111K | ﹤0.01% |
3,167
-6,230
| -66% | -$295K |
2022 Q1
4 quarters
|
|
5128
BlackRock Enhanced Captial and Income Fund
CII
$1.05B
| $111K | ﹤0.01% |
6,195
+6,182
| +47,554% | +$111K |
2022 Q3
2 quarters
|
|
5129
Invesco Municipal Trust
VKQ
$465M
| $111K | ﹤0.01% |
+11,147
| New | +$109K |
2023 Q1
0 quarters
|
|
5130
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $111K | ﹤0.01% |
3,447
| – | – |
2022 Q4
1 quarter
|
|
5131
PUT
Corsair Gaming
CRSR
$1.46B
| $110K | ﹤0.01% |
6,000
+5,900
| +5,900% | +$95.9K |
2022 Q4
1 quarter
|
|
5132
VanEck IG Floating Rate ETF
FLTR
$3.41B
| $110K | ﹤0.01% |
4,411
+1,335
| +43% | +$33.5K |
2020 Q4
9 quarters
|
|
5133
Nautilus Biotechnolgy
NAUT
$238M
| $110K | ﹤0.01% |
39,891
+9,965
| +33% | +$20.9K |
2021 Q4
5 quarters
|
|
|
UFOX
5134
Defiance Space and Connective Tech ETF
UFOX
$909M
| $110K | ﹤0.01% |
3,352
-55,602
| -94% | -$1.78M |
2020 Q4
9 quarters
|
|
|
VBIV
5135
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $110K | ﹤0.01% |
12,070
+3,975
| +49% | +$56.3K |
2019 Q2
15 quarters
|
|
|
CRGE
5136
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $110K | ﹤0.01% |
100,568
+26,057
| +35% | +$32.8K |
2022 Q2
3 quarters
|
|
5137
PUT
lululemon athletica
LULU
$10.3B
| $109K | ﹤0.01% |
300
-99,700
| -100% | -$31.3M |
2022 Q3
2 quarters
|
|
5138
BlackRock MuniHoldings Fund
MHD
$1.76B
| $109K | ﹤0.01% |
+9,046
| New | +$108K |
2023 Q1
0 quarters
|
|
5139
Motorcar Parts of America
MPAA
$201M
| $109K | ﹤0.01% |
14,673
+3,577
| +32% | +$42.6K |
2017 Q4
21 quarters
|
|
5140
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.98B
| $109K | ﹤0.01% |
2,907
-351
| -11% | -$13.6K |
2015 Q2
31 quarters
|
|
|
VBNK
5141
VersaBank
VBNK
$725M
| $109K | ﹤0.01% |
14,800
-1,900
| -11% | -$14.3K |
2021 Q3
6 quarters
|
|
|
LBC
5142
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $109K | ﹤0.01% |
11,455
-42,795
| -79% | -$474K |
2018 Q1
20 quarters
|
|
5143
WisdomTree International Multifactor Fund
DWMF
$33.2M
| $108K | ﹤0.01% |
4,312
+1,837
| +74% | +$45.2K |
2022 Q4
1 quarter
|
|
5144
State Street DoubleLine Short Duration Total Return Tactical ETF
STOT
$529M
| $108K | ﹤0.01% |
+2,330
| New | +$108K |
2023 Q1
0 quarters
|
|
5145
Aptus Collared Investment Opportunity ETF
ACIO
$2.42B
| $107K | ﹤0.01% |
3,558
-1,708
| -32% | -$50.5K |
2022 Q4
1 quarter
|
|
5146
AllianzIM U.S. Equity Buffer10 Jan ETF
JANT
$62.6M
| $107K | ﹤0.01% |
+3,970
| New | +$104K |
2023 Q1
0 quarters
|
|
5147
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.66B
| $107K | ﹤0.01% |
1,519
-1,292
| -46% | -$94K |
2022 Q4
1 quarter
|
|
5148
Barings BDC
BBDC
$895M
| $107K | ﹤0.01% |
13,531
-23,869
| -64% | -$200K |
2021 Q3
6 quarters
|
|
5149
Bankwell Financial Group
BWFG
$527M
| $107K | ﹤0.01% |
4,322
+204
| +5% | +$5.89K |
2017 Q4
21 quarters
|
|
5150
C4 Therapeutics
CCCC
$368M
| $107K | ﹤0.01% |
33,863
-66,619
| -66% | -$392K |
2020 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.